Larry Rubinstein
National Institutes of Health(US)Applied Materials (Israel)(IL)Zimmer Biomet (United States)(US)National Cancer Institute(MY)National Cancer Institute(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Statistical Methods in Clinical Trials, PARP inhibition in cancer therapy, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)(2008)28,927 cited
- → New Guidelines to Evaluate the Response to Treatment in Solid Tumors(2000)15,689 cited
- → Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer(1995)2,996 cited
- → An Information-Intensive Approach to the Molecular Pharmacology of Cancer(1997)1,178 cited
- → Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm(1989)969 cited
- → Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines(1990)928 cited